Skip to main content
Journal cover image

P1102 Mechanism of pexelizumabs mortality benefit in acute myocardial infarction patients treated with primary percutaneous coronary intervention

Publication ,  Conference
ARMSTRONG, P
Published in: European Heart Journal
March 2003

Duke Scholars

Published In

European Heart Journal

DOI

ISSN

0195-668X

Publication Date

March 2003

Volume

24

Issue

5

Start / End Page

199 / 199

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
ARMSTRONG, P. (2003). P1102 Mechanism of pexelizumabs mortality benefit in acute myocardial infarction patients treated with primary percutaneous coronary intervention. In European Heart Journal (Vol. 24, pp. 199–199). Elsevier BV. https://doi.org/10.1016/s0195-668x(03)94394-6
ARMSTRONG, P. “P1102 Mechanism of pexelizumabs mortality benefit in acute myocardial infarction patients treated with primary percutaneous coronary intervention.” In European Heart Journal, 24:199–199. Elsevier BV, 2003. https://doi.org/10.1016/s0195-668x(03)94394-6.
ARMSTRONG, P. “P1102 Mechanism of pexelizumabs mortality benefit in acute myocardial infarction patients treated with primary percutaneous coronary intervention.” European Heart Journal, vol. 24, no. 5, Elsevier BV, 2003, pp. 199–199. Crossref, doi:10.1016/s0195-668x(03)94394-6.
Journal cover image

Published In

European Heart Journal

DOI

ISSN

0195-668X

Publication Date

March 2003

Volume

24

Issue

5

Start / End Page

199 / 199

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology